The Effects of Common Genetic Variation in 96 Genes Involved in Thyroid Hormone Regulation on TSH and FT4 Concentrations.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
17 05 2022
Historique:
received: 08 11 2021
pubmed: 10 3 2022
medline: 20 5 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

While most of the variation in thyroid function is determined by genetic factors, single nucleotide polymorphisms (SNPs) identified via genome-wide association analyses have only explained ~5% to 9% of this variance so far. Most SNPs were in or nearby genes with no known role in thyroid hormone (TH) regulation. Therefore, we performed a large-scale candidate gene study investigating the effect of common genetic variation in established TH regulating genes on serum thyrotropin [thyroid-stimulating hormone (TSH)] and thyroxine (FT4) concentrations. SNPs in or within 10 kb of 96 TH regulating genes were included (30 031 TSH SNPs, and 29 962 FT4 SNPs). Associations were studied in 54 288 individuals from the ThyroidOmics Consortium. Linkage disequilibrium-based clumping was used to identify independently associated SNPs. SNP-based explained variances were calculated using SumHer software. We identified 23 novel TSH-associated SNPs in predominantly hypothalamic-pituitary-thyroid axis genes and 25 novel FT4-associated SNPs in mainly peripheral metabolism and transport genes. Genome-wide SNP variation explained ~21% (SD 1.7) of the total variation in both TSH and FT4 concentrations, whereas SNPs in the 96 TH regulating genes explained 1.9% to 2.6% (SD 0.4). Here we report the largest candidate gene analysis on thyroid function, resulting in a substantial increase in the number of genetic variants determining TSH and FT4 concentrations. Interestingly, these candidate gene SNPs explain only a minor part of the variation in TSH and FT4 concentrations, which substantiates the need for large genetic studies including common and rare variants to unravel novel, yet unknown, pathways in TH regulation.

Identifiants

pubmed: 35262175
pii: 6545200
doi: 10.1210/clinem/dgac136
pmc: PMC9315164
doi:

Substances chimiques

Thyroid Hormones 0
Thyrotropin 9002-71-5
Thyroxine Q51BO43MG4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2276-e2283

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Nat Commun. 2015 Mar 06;6:5681
pubmed: 25743335
Nature. 2019 Jun;570(7759):71-76
pubmed: 31118516
BMC Endocr Disord. 2017 Mar 2;17(1):14
pubmed: 28253873
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
J Clin Endocrinol Metab. 2020 Jun 1;105(6):
pubmed: 32271924
Cell J. 2019 Jan;20(4):604-607
pubmed: 30124010
J Clin Endocrinol Metab. 2022 May 17;107(6):e2276-e2283
pubmed: 35262175
J Clin Endocrinol Metab. 2004 Mar;89(3):1181-7
pubmed: 15001606
JAMA Cardiol. 2019 Feb 1;4(2):144-152
pubmed: 30673084
Nat Rev Endocrinol. 2015 Jan;11(1):29-42
pubmed: 25350068
Eur Thyroid J. 2021 Nov;10(6):439-446
pubmed: 34950598
Circ Res. 2017 Dec 8;121(12):1392-1400
pubmed: 29089349
J Clin Endocrinol Metab. 2016 Nov;101(11):4270-4282
pubmed: 27603906
Endocrinology. 2008 Oct;149(10):5307-14
pubmed: 18566113
Thyroid. 2016 Oct;26(10):1457-1465
pubmed: 27539006
J Clin Endocrinol Metab. 2007 Feb;92(2):636-40
pubmed: 17105838
Eur J Endocrinol. 2011 May;164(5):773-80
pubmed: 21317282
Clin Endocrinol (Oxf). 2007 Jun;66(6):827-32
pubmed: 17408420
J Clin Endocrinol Metab. 2008 Aug;93(8):3075-81
pubmed: 18492748
J Clin Endocrinol Metab. 2015 Oct;100(10):3718-24
pubmed: 26262438
Arch Intern Med. 2012 May 28;172(10):799-809
pubmed: 22529182
J Clin Invest. 2012 Sep;122(9):3035-43
pubmed: 22945636
J Mol Evol. 2020 Jan;88(1):88-103
pubmed: 31451837
Clin Endocrinol (Oxf). 2009 Jun;70(6):954-60
pubmed: 18793344
J Mol Endocrinol. 2010 Jan;44(1):1-11
pubmed: 19541799
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2719-2728
pubmed: 28482002
Endocr Rev. 2015 Apr;36(2):214-44
pubmed: 25751422
Endocrinology. 2008 Sep;149(9):4695-701
pubmed: 18499754
Nat Commun. 2018 Oct 26;9(1):4455
pubmed: 30367059
J Clin Endocrinol Metab. 2003 Jun;88(6):2880-8
pubmed: 12788902
Nat Genet. 2019 Feb;51(2):277-284
pubmed: 30510236
Nat Commun. 2020 Feb 21;11(1):995
pubmed: 32081864
J Pers Med. 2021 Dec 06;11(12):
pubmed: 34945778
J Clin Endocrinol Metab. 2014 Apr;99(4):1213-9
pubmed: 24564323
Int J Epidemiol. 2017 Aug 1;46(4):1099-1100j
pubmed: 28082374
Nat Genet. 2020 Apr;52(4):458-462
pubmed: 32203469
J Clin Endocrinol Metab. 2015 Jun;100(6):2181-91
pubmed: 25856213
Nature. 2015 Feb 5;518(7537):102-6
pubmed: 25487149
BMC Med. 2021 Nov 3;19(1):266
pubmed: 34727949
Best Pract Res Clin Endocrinol Metab. 2017 Mar;31(2):129-142
pubmed: 28648503
Nat Rev Genet. 2002 May;3(5):391-7
pubmed: 11988764
Neurology. 2016 Oct 18;87(16):1688-1695
pubmed: 27638924
Nat Commun. 2020 Aug 7;11(1):3981
pubmed: 32769997
Circulation. 2017 Nov 28;136(22):2100-2116
pubmed: 29061566
J Hum Genet. 2021 Jan;66(1):11-23
pubmed: 32948841

Auteurs

Rosalie B T M Sterenborg (RBTM)

Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Tessel E Galesloot (TE)

Radboud University Medical Center, Radboud Institute for Health Sciences, Department for Health Evidence, Nijmegen, The Netherlands.

Alexander Teumer (A)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.

Romana T Netea-Maier (RT)

Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.

Doug Speed (D)

Department of Quantitative Genetics and Genomics, Aarhus University, Aarhus, Denmark.

Marcel E Meima (ME)

Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

W Edward Visser (WE)

Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Johannes W A Smit (JWA)

Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.

Robin P Peeters (RP)

Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Marco Medici (M)

Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH